Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEAT-HF II: Mirabegron in Heart Failure
NCT03926754Phase 3Completed
- Start
- Jan 2017
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirabegron in heart failure (HF). Started Jan 2017; status: completed.
02
Drugs
mirabegron
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03926754.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03926754.